The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,694.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products, with a completion date of February 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The delivery order, valued at $2,310.95, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of COSENTYX SENSOREADY 150 MG PEN ML pharmaceutical products. The $3,043.90 delivery order has an ultimate completion date of March 21, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a ceiling value of $7,609.75 and a period of performance through April 10, 2024. This award is a child contract associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's...
The Defense Logistics Agency (DLA) awarded a $7,660.53 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $5,556.34 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The delivery order has a potential value of $10,695.50 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not subject to any set-aside requirements. This delivery order is issued under a larger indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX 300 mg dose-2 syringes. The contract has a potential value of $18,680.41 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations mentioned. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $102,235.72 to the Amerisourcebergen Drug Corp, Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. This Delivery Order contract is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through...